Finance

Lists
COHANCE:NSE
Cohance Lifesciences Ltd
₹464,70
+1,03%
(+4,75) 1D
16 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for COHANCE...
Open
₹460,45
High
₹467,35
Low
₹458,10
Mkt. cap
177,79 mjd
Avg. vol.
1,08 m
Volume
763,45 k
P/E ratio
167,81
52-wk high
₹917,85
52-wk low
₹266,70
EPS
₹2,77
No. of employees
3 k
Open
₹460,45
High
₹467,35
Low
₹458,10
Mkt. cap
177,79 mjd
Avg. vol.
1,08 m
Volume
763,45 k
P/E ratio
167,81
52-wk high
₹917,85
52-wk low
₹266,70
EPS
₹2,77
No. of employees
3 k
News stories
From web sources and news partners
About Cohance Lifesciences Ltd
CEO-
Employees2,81 k
Founded1989
Headquarters-
SectorPharmaceutical industry
Websitecohance.com
Last report
05 Aug. 2026
Fiscal period
Q1 2027
-₹0,63 / ₹1,00
-163,00%miss
Revenue / Est. (INR)
4,22 mjd / 5,00 mjd
-15,61%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
5,56 mjd
5,45 mjd
6,19 mjd
4,22 mjd
Cost of goods sold
1,41 mjd
1,59 mjd
3,56 mjd
1,20 mjd
Cost of revenue
1,41 mjd
1,59 mjd
3,56 mjd
1,20 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,27 mjd
1,19 mjd
1,47 mjd
1,33 mjd
Operating expense
3,38 mjd
3,37 mjd
2,14 mjd
3,50 mjd
Total operating expenses
4,79 mjd
4,96 mjd
5,70 mjd
4,71 mjd
Operating income
769,30 m
484,10 m
491,10 m
-483,80 m
Other non operating income
156,00 m
61,60 m
-310,30 m
122,50 m
EBT including unusual items
837,70 m
406,00 m
199,10 m
-428,70 m
EBT excluding unusual items
837,70 m
454,60 m
171,40 m
-428,70 m
Income tax expense
173,80 m
115,80 m
116,00 m
23,20 m
Effective tax rate
20,75%
28,52%
58,26%
-5,41%
Other operating expenses
1,67 mjd
1,72 mjd
152,80 m
1,68 mjd
Net income
740,80 m
367,20 m
195,50 m
-241,20 m
Net profit margin
13,33%
6,74%
3,16%
-5,71%
Earnings per share
1,93
0,55
0,68
-0,63
Interest and investment income
-
-
27,30 m
-
Interest expense
-87,60 m
-91,10 m
-91,90 m
-67,40 m
Net interest expenses
-87,60 m
-91,10 m
-64,60 m
-67,40 m
Depreciation and amortization charges
440,20 m
469,40 m
512,30 m
495,40 m
EBITDA
1,23 mjd
677,82 m
865,38 m
-15,48 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme